The absorption of iron is disturbed in recombinant human erythropoietin-treated peritoneal dialysis patients

Nephrology Dialysis Transplantation

Volumn 13, Issue 10, 1998, Pages 2578-2582

  Kooistra, Menno P ^a,b,d   Marx, Joannis J M ^b,c  

^a Found Home Dialysis Midden W N   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d Stichting Thuisdialyse Midden W N   (Netherlands)

Author keywords

Anaemia; Erythropoietin; Iron absorption; Peritoneal dialysis

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; BLEEDING; BLOOD SAMPLING; BONE MARROW; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IRON ABSORPTION; IRON THERAPY; ISOTOPE LABELING; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ABSORPTION; ADOLESCENT; ADULT; ANEMIA, IRON-DEFICIENCY; ERYTHROPOIESIS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; INFUSIONS, INTRAVENOUS; IRON; IRON COMPOUNDS; KIDNEY DISEASES; MALE; PERITONEAL DIALYSIS; RECEPTORS, TRANSFERRIN;

EID: 0031663035     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.10.2578     Document Type: Article

References (25)

1. Eschbach JW, Egrie JC, Downing MR, Brown JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987; 316: 73-78
2. Van Wyck DB. Iron management during recombinant human erythropoietin therapy. Am J Kidney Dis 1989; 14 [suppl. 1 ]: 9-13
3. Kooistra MP, van Es A, Struyvenberg A, Marx JJM. Iron metabolism in patients with the anaemia of end-stage renal disease during treatment with recombinant human erythropoietin. Br J Haematol 1991; 79: 634-639
4. Macdougall IC, Cavill I, Hulme B, et al. Detection of functional iron deficiency during erythropoietin treatment: a new approach. Br Med J 1992; 304: 225-226
5. Macdougall IC. Poor response to erythropoietin: practical guidelines on investigation and management. Nephrol Dial Transplant 1995; 10: 607-614
6. Macdougall IC, David Hutton R, Cavill I, Coles GA, Williams JD. Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously. Br Med J 1989: 299: 157-158
7. Sunder-Plassmann G, Hörl WH. Importance of iron supply for erythropoietin therapy. Nephrol Dial Transplant 1995; 10: 2070-2076
8. Donnelly SM, Posen GA, Ali MAM. Oral iron absorption in hemodialysis patients treated with erythropoietin. Clin Invest Med 1991; 14: 271-276
9. Goch J, Birgegard G, Danielson B, Wilkström B. Iron absorption in patients with chronic uremia on maintenance hemodialysis and in healthy volunteers measured with a simple oral iron load test. Nephron 1996; 73: 403-406
10. Kooistra MP, Niemantsverdriet EC, van Es A, Mol-Beermann EM, Struyvenberg A, Marx JJM. Iron absorption in erythropoietin treated haemodialysis patients: effects of iron availability, inflammation and aluminium. Nephrol Dial Transplant, 1998; 13: 82-88
11. Kooistra MP, Marx JJM. The management of iron metabolism in recombinant human erythropoietin treated dialysis patients by Dutch nephrologists. Nephrol Dial Transplant 1997; 12: 879-883
12. Gokal R, Miljard PR, Weatherall DJ, Calendar STE, Ledingham JCG, Oliver DO. Iron metabolism in haemodialysis patients: a study of the management of iron therapy and overload. Q J Med 1979; 48: 369-391
13. Milman N. Iron absorption measured by whole body counting and the relation to marrow iron stores in chronic uremia. Clin Nephrol 1982: 17: 77-81
14. Domoto DT, Martin KJ. Failure of CAPD patients to respond to an oral iron absorption test. Adv Peritoneal Dial 1992; 8: 102-104
15. Tinawi M, Martin KJ, Bastani B. Oral iron absorption test in patients on CAPSD: comparison of ferrous sulfate and a polysaccharide ferric complex. Nephron 1996; 74: 291-294
16. Marx JJM. Mucosal uptake, mucosal transfer and retention of iron, measured by whole body counting. Scand J Haematol 1979; 23: 293-302
17. Ploem JE, de Wael J, Verloop MC, Punt K. Sideruria following a single dose of desferrioxamine-B as a diagnostic test in iron overload. Br J Haematol 1966; 4: 396-408
18. Huebers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood 1990; 75: 102-107
19. Eschbach JW, Cook JD, Scribner BH, Finch C. Iron balance in hemodialysis patients. Ann Intern Med 1977; 87: 710-713
20. Hughes RT, Smith T. Hesp R, el al. Regulation of iron absorption in iron loaded subjects with end stage renal disease: effects of treatment with recombinant human erythropoietin and reduction of iron stores. Br J Haematol 1992; 82: 445-454
21. Moore LW, Acchiardo S, Sargent JA, Burk L. Incidence, causes, and treatment of iron deficiency anemia in hemodialysis patients. J Renal Nutr 1992; 3: 105-112
22. Brozovich B, Cattell WR, Cottrall MF, et al. Iron metabolism in patients undergoing regular dialysis therapy. Br Med J 1971; 1: 695-698
23. Lindsay RM, Burton JA, Edward N. Dialyzer blood loss. Clin Nephrol 1973; 1: 29-34
24. Longnecker RE, Gofinet JA, Hendler ED. Blood loss during maintenance hemodialysis. Trans Am Soc Artif Intern Organs 1974;20: 135-140
25. Cook JD, Lipschitz DA, Miles LE, Finch CA. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 1974;27: 681-687